Theranostics, Which Combines Therapeutic And Diagnostic Uses Into A Single Agent
The move from traditional medicine to a modern personalized and precision medical approach is made possible by Theranostics, which is defined as the integration of medicines, nanoscience, and diagnostics. Additionally known as companion diagnostics (CDx), theragnostics, pharmacodiagnostics, individualized medical care, personalized therapy, and personalized medicine technology, theranostics is a field of study. A recent area of medicine called “theranostics” combines certain medicines with particular diagnostic tests.
Drug delivery, diagnosis, and treatment response monitoring—all of which are primarily employed to treat cancer—are made possible by Theranostics, which combines therapeutic and diagnostic uses into a single agent. This therapy uses positron emission tomography to locate the tumor and diagnostic imaging to determine whether target receptors are present on cancer cells. It also uses a combination of imaging and molecular radiotherapy, precise radiation therapy targeted at receptors, and molecular target detection.
